ScripBroad Institute co-founder Stuart Schreiber is teaming up with an all-star list of scientists and financial backers to found Arena BioWorks, which Schreiber said is intended to let scientists focus o
ScripSynthetic biology company Gingko BioWorks, which went public less than a month ago via a $1.6bn SPAC deal, has been branded a “colossal scam” by short selling activists Scorpion Capital. Gingko is one
In VivoIn 2019, attention-grabbing headlines such as Roche ’s acquisition of Spark Therapeutics Inc. for $4.8bn, Biogen Inc. ’s $877m play for Nightstar Therapeutics PLC , and Vertex Pharmaceuticals In
ScripOhio State University has brought on a former biopharma executive to lead its cancer-specific Drug Development Institute with the goal of enhancing and optimizing promising oncology research for pot